Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.12
+0.14 (1.56%)
At close: Mar 9, 2026, 4:00 PM EDT
10.75
+1.63 (17.87%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Zevra Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 83.23 | -105.51 | -46.05 | -26.77 | -8.56 | Upgrade
|
| Depreciation & Amortization | 4.05 | 6.39 | 1.01 | 0.94 | 0.26 | Upgrade
|
| Other Amortization | - | - | - | - | 0.15 | Upgrade
|
| Loss (Gain) From Sale of Assets | -148.26 | 0.22 | 0.16 | 0.01 | 0.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | 58.71 | - | - | 17.66 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.28 | -0.87 | -0.61 | 0.58 | - | Upgrade
|
| Stock-Based Compensation | 12.71 | 15.38 | 6.18 | 4.52 | 2.74 | Upgrade
|
| Other Operating Activities | 17.75 | 21.37 | -0.1 | -15.25 | 16.13 | Upgrade
|
| Change in Accounts Receivable | -11.98 | 6.87 | -9.08 | -6.77 | 1.05 | Upgrade
|
| Change in Inventory | -1.31 | -8.87 | 0.21 | 0.15 | - | Upgrade
|
| Change in Accounts Payable | -15.59 | -3.6 | 11.13 | 3.13 | -1.11 | Upgrade
|
| Change in Other Net Operating Assets | 2.36 | -1.04 | 3.63 | 3.09 | -0.3 | Upgrade
|
| Operating Cash Flow | -1.6 | -69.67 | -33.54 | -18.72 | 10.44 | Upgrade
|
| Capital Expenditures | -0.84 | - | -0.3 | -0.09 | -0.1 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.45 | - | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | -30.4 | -14.09 | - | Upgrade
|
| Investment in Securities | -131.49 | -16.16 | 13.31 | -22.54 | -15.42 | Upgrade
|
| Other Investing Activities | 150 | -6 | - | - | - | Upgrade
|
| Investing Cash Flow | 18.13 | -22.16 | -17.39 | -36.72 | -15.52 | Upgrade
|
| Long-Term Debt Issued | - | 60.07 | 43.69 | 14.07 | - | Upgrade
|
| Long-Term Debt Repaid | -0.37 | -43.13 | -18.1 | -1.32 | -38.1 | Upgrade
|
| Net Debt Issued (Repaid) | -0.37 | 16.94 | 25.59 | 12.75 | -38.1 | Upgrade
|
| Issuance of Common Stock | 12.44 | 67.26 | 6.32 | 0.32 | 158.24 | Upgrade
|
| Repurchase of Common Stock | - | - | -3.45 | -4.72 | -2.81 | Upgrade
|
| Other Financing Activities | - | -2.09 | - | - | -4.22 | Upgrade
|
| Financing Cash Flow | 12.06 | 82.11 | 28.46 | 8.35 | 113.11 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | 0.45 | 0.04 | 0.2 | - | Upgrade
|
| Net Cash Flow | 28.62 | -9.26 | -22.42 | -46.88 | 108.02 | Upgrade
|
| Free Cash Flow | -2.43 | -69.67 | -33.83 | -18.81 | 10.34 | Upgrade
|
| Free Cash Flow Margin | -2.28% | -295.04% | -123.20% | -185.12% | 36.08% | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -1.51 | -0.95 | -0.55 | 0.35 | Upgrade
|
| Cash Interest Paid | - | 5.26 | 0.46 | 0.32 | 0.22 | Upgrade
|
| Levered Free Cash Flow | -14.66 | -36.36 | -10.32 | -10 | 6.31 | Upgrade
|
| Unlevered Free Cash Flow | -9.68 | -31.77 | -9.39 | -9.79 | 6.39 | Upgrade
|
| Change in Working Capital | -26.51 | -6.64 | 5.88 | -0.41 | -0.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.